PREQUEL study- Prevention after ECT with Quetiapine extended release of Lowered Mood (in remitted Major Depressive Disorder following ECT)

Trial Profile

PREQUEL study- Prevention after ECT with Quetiapine extended release of Lowered Mood (in remitted Major Depressive Disorder following ECT)

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Quetiapine (Primary) ; Antidepressants
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms PREQUEL
  • Most Recent Events

    • 04 Mar 2014 Status changed from not yet recruiting to discontinued as reported by Australian & NZ Clinical Trials Register.
    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top